Notably, although the results of preclinical studies and cohort studies suggest that kisspeptin improves reproductive hormone secretion and ovulation in some animal models of anovulation PCOS, the effect on PCOS patients remains unknown. Here, KISS1 is linked to polycystic ovary syndrome.